{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:35:40Z","timestamp":1792467340368,"version":"4.5.0"},"reference-count":39,"publisher":"Informa UK Limited","issue":"21","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2015,11,30]]},"DOI":"10.2217\/fon.15.232","type":"journal-article","created":{"date-parts":[[2015,9,25]],"date-time":"2015-09-25T09:48:10Z","timestamp":1443174490000},"page":"2865-2871","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":50,"title":["Denosumab: A New Agent in the Management of Hypercalcemia of Malignancy"],"prefix":"10.1080","volume":"11","author":[{"given":"Sonali","family":"Thosani","sequence":"first","affiliation":[{"name":"Department of Endocrine Neoplasia & Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mimi I","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Endocrine Neoplasia & Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2015,9,25]]},"reference":[{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp042806"},{"issue":"5","key":"e_1_3_3_4_1","first-page":"1551","article-title":"Cancer-induced hypercalcemia","volume":"29","author":"Lumachi F","year":"2009","unstructured":"Lumachi F , BrunelloA, RomaA, BassoU. Cancer-induced hypercalcemia. Anticancer Res.29(5), 1551\u20131555 (2009).","journal-title":"Anticancer Res."},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-112-7-499"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-7216-0139-7.50065-X"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007090981"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/bmb\/ldu016"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-06-1992"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2016"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199011083231907"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1001"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02470312"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-149-4-200808190-00007"},{"key":"e_1_3_3_15_1","unstructured":"Denosumab calcitonin zoledronic acid and pamidronate. http:\/\/online.lexi.com."},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1869"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S8756-3282(95)00150-6"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650101008"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/030097498441155"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-005-1100-2"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.2.558"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.2174\/157340612801216355"},{"issue":"6","key":"e_1_3_3_23_1","first-page":"392","article-title":"Bisphosphonates, hypercalcemia of malignancy, and osteonecrosis of the jaw","volume":"53","author":"Wynn RL","year":"2005","unstructured":"Wynn RL . Bisphosphonates, hypercalcemia of malignancy, and osteonecrosis of the jaw. Gen. Dent.53(6), 392\u2013395 (2005).","journal-title":"Gen. Dent."},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2010.11.020"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.29.7101"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)62344-6"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2010-0154"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.090810"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1210\/en.2004-1583"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-156-12-201206190-00026"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.41.7923"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2013.06.002"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-202861"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2014.07.005"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-3031"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.4158\/EP14410.OR"},{"issue":"2","key":"e_1_3_3_37_1","first-page":"143","article-title":"Denosumab in hypercalcemia of malignancy: a case series","volume":"21","author":"Dietzek A","year":"2015","unstructured":"Dietzek A , ConnellyK, CotugnoM, BartelS, McdonnellAM. Denosumab in hypercalcemia of malignancy: a case series. J. Oncol. Pract.21(2), 143\u2013147 (2015).","journal-title":"J. Oncol. Pract."},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s005200050008"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.04.017"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12519"},{"key":"e_1_3_3_41_1","unstructured":"XGEVA Prescribing Information. Amgen Inc. (2015). http:\/\/pi.amgen.com\/united_states\/xgeva\/xgeva_pi.pdf."}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon.15.232","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:45:42Z","timestamp":1719125142000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon.15.232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,25]]},"references-count":39,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2015,11,30]]}},"alternative-id":["10.2217\/fon.15.232"],"URL":"https:\/\/doi.org\/10.2217\/fon.15.232","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,25]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2015-09-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}